Peter Lynch · Growth at a reasonable price (GARP)
Is ANI Pharmaceuticals, Inc. (ANIP) a Peter Lynch Stock?
Strong GARP candidate: growth at a reasonable price.
65/100
Mixto
4/6 criterios cumplidos
Los criterios de Peter Lynch, aplicados a ANIP
PEG ≤ 1.0
clave-
EPS CAGR ≥ 15%
clave-
Revenue CAGR ≥ 10%
42.2%
Net margin > 0
9.7%
Cómo se valora ANIP en otras estrategias
Datos financieros en vivo
Cap. mercado
$1.67B
PER (TTM)
18.3x
ROIC (TTM)
8.17%
Margen bruto
65.94%
Otros análisis Peter Lynch
Preguntas frecuentes
What is ANIP's Peter Lynch fit score?
ANIP scores 65/100 on our Peter Lynch fit engine. Strong GARP candidate: growth at a reasonable price.
Does Peter Lynch actually own ANIP?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends ANIP.
How often is this score updated?
ANIP's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Peter Lynch posea o recomiende ANIP personalmente.
